With its Q320 earnings, BioPorto announced that its COVID-19 antigen test it has under development would be entering the clinic. The gathering of samples is expected to start imminently and to be complete by the end of December 2020. The company believes that this timeline supports the potential commercialisation of the product in early 2021, if the results of the study are compelling.
19 Nov 2020
BioPorto Diagnostics - COVID-19 test to enter the clinic
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
BioPorto Diagnostics - COVID-19 test to enter the clinic
With its Q320 earnings, BioPorto announced that its COVID-19 antigen test it has under development would be entering the clinic. The gathering of samples is expected to start imminently and to be complete by the end of December 2020. The company believes that this timeline supports the potential commercialisation of the product in early 2021, if the results of the study are compelling.